Triazole-fused pyrimidines in target-based anticancer drug discovery
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triazole-fused pyrimidines in target-based anticancer drug discovery
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 249, Issue -, Pages 115101
Publisher
Elsevier BV
Online
2023-01-11
DOI
10.1016/j.ejmech.2023.115101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GCN2: roles in tumour development and progression
- (2022) Lyssa T. Gold et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors
- (2022) Heba S. Mohamed et al. BIOORGANIC CHEMISTRY
- Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine
- (2022) Max Van Hoof et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
- (2022) Ying Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T+ Itpr3tf/J mouse model of autism
- (2022) Norah A. Albekairi et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor
- (2022) Sai-Qi Wang et al. Acta Pharmaceutica Sinica B
- Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents
- (2022) Paola Oliva et al. Pharmaceutics
- Pharmacokinetic and pharmacodynamic activity evaluation of MAK683, a selective oral embryonic ectoderm development (EED) inhibitor, in adults with advanced malignancies in a first-in-human study.
- (2022) Vincent Ribrag et al. JOURNAL OF CLINICAL ONCOLOGY
- Design and synthesis of novel pipernonaline derivatives as anti-austerity agents against human pancreatic cancer PANC-1 cells
- (2022) Takuya Okada et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update
- (2022) Kritika Engle et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
- (2021) Xing-Jie Dai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems
- (2021) Ilenia Grieco et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural insights into the activation of chemokine receptor CXCR2
- (2021) Kaiwen Liu et al. FEBS Journal
- Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
- (2021) Zaira Spinello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect
- (2021) Jianhong Yang et al. Science Advances
- The Game of Tubulins
- (2021) Maria Alvarado Kristensson Cells
- Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines
- (2021) Xian-Sen Huo et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of PI3K inhibitors: advances in clinical trials and new strategies (Review)
- (2021) Dandan Meng et al. PHARMACOLOGICAL RESEARCH
- Anticancer drug resistance: An update and perspective
- (2021) Ruth Nussinov et al. DRUG RESISTANCE UPDATES
- Discovery of the antitumor activities of a potent DCN1 inhibitor compound 383 targeting LSD1 in gastric cancer
- (2021) Zan Song et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase
- (2021) Sharan K. Bagal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Benzocyclic Sulfone Derivatives as Potent CXCR2 Antagonists for Cancer Immunotherapy
- (2021) Yi Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance
- (2021) Shuai Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preclinical Pharmacokinetics and Metabolism of MAK683, a Clinical Stage Selective Oral Embryonic Ectoderm Development (EED) Inhibitor for Cancer Treatment
- (2021) Ji Yue (Jeff) Zhang et al. XENOBIOTICA
- Targeting the Integrated Stress Response in Cancer Therapy
- (2021) Xiaobing Tian et al. Frontiers in Pharmacology
- Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance
- (2021) Yeelon Yeoh et al. PeerJ
- USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma
- (2021) Cristian Prieto-Garcia et al. Cells
- Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
- (2021) Jordan A. Harry et al. Frontiers in Oncology
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- CK1δ as a potential therapeutic target to treat bladder cancer
- (2020) Yu-Chen Lin et al. Aging-US
- LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer
- (2020) Xi Jin et al. Molecular Cancer
- A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
- (2020) Nagaraju Kerru et al. MOLECULES
- Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
- (2020) Miguel A. Ortega et al. Journal of Oncology
- Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease
- (2020) Brian Thompson et al. HUMAN GENETICS
- The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion
- (2020) Lobna Elkhadragy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biological activities of [1,2,4]triazolo[1,5-a]pyrimidines and analogs
- (2020) Sergio Pinheiro et al. MEDICINAL CHEMISTRY RESEARCH
- Epigenetic Therapies for Cancer
- (2020) Susan E. Bates NEW ENGLAND JOURNAL OF MEDICINE
- The therapeutic importance of acid-base balance
- (2020) Bianca N. Quade et al. BIOCHEMICAL PHARMACOLOGY
- Dual PI3K/mTOR inhibitor PKI-402 suppresses the growth of ovarian cancer cells by degradation of Mcl-1 through autophagy
- (2020) Xiaoqing Hu et al. BIOMEDICINE & PHARMACOTHERAPY
- Biochemical, Cellular and Structural Characterization of Novel and Selective ERK3 Inhibitors
- (2020) Ulrich Grädler et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An overview of carbohydrate-based carbonic anhydrase inhibitors
- (2020) Doretta Cuffaro et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective
- (2020) Xing-Jie Dai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer
- (2020) M. Cynthia Martin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators
- (2020) Shuai Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- 1,2,4-Triazolo[1,5-a]pyrimidines in drug design
- (2019) Killian Oukoloff et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)
- (2019) Zhonghua Li et al. Acta Pharmaceutica Sinica B
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5-a]pyrimidine-Based Inhibitors Targeting the DCN1–UBC12 Protein–Protein Interaction
- (2019) Shuai Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Experience-based discovery (EBD) of aryl hydrazines as new scaffolds for the development of LSD1/KDM1A inhibitors
- (2019) Zhong-Rui Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1/KDM1A inhibitors
- (2019) Shuai Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation
- (2019) Anne Laugesen et al. MOLECULAR CELL
- PAX proteins and their role in pancreas
- (2019) Antojenifer Panneerselvam et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018)
- (2019) Kashif Haider et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities
- (2019) Fang Yang et al. BIOORGANIC CHEMISTRY
- Small molecule modulators targeting protein kinase CK1 and CK2
- (2019) Yuting Qiao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A MYC–GCN2–eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer
- (2019) Stefanie Schmidt et al. NATURE CELL BIOLOGY
- Casein Kinase 1 Delta Regulates Cell Proliferation, Response to Chemotherapy and Migration in Human Ovarian Cancer Cells
- (2019) Elena Laura Mazzoldi et al. Frontiers in Oncology
- Targeting CDK2 in cancer: challenges and opportunities for therapy
- (2019) Solomon Tadesse et al. DRUG DISCOVERY TODAY
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- [1,2,3]Triazolo[4,5-d]pyrimidine derivatives incorporating (thio)urea moiety as a novel scaffold for LSD1 inhibitors
- (2019) Zhong-Hua Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors
- (2019) Mohamed A. Said et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting CXCR1/2: The medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead
- (2019) Jinxin Che et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A patent review of BRD4 inhibitors (2013-2019)
- (2019) Tian Lu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
- (2019) Huanjie Yang et al. SEMINARS IN CANCER BIOLOGY
- Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors
- (2019) Zhenzhen Liu et al. Acta Pharmaceutica Sinica B
- Targeting the microenvironment in solid tumors
- (2018) Carmen Belli et al. CANCER TREATMENT REVIEWS
- The role of tumor angiogenesis as a therapeutic target in colorectal cancer
- (2018) Francesca Battaglin et al. Expert Review of Anticancer Therapy
- Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
- (2018) Jared T. Hammill et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
- (2018) Claudiu T. Supuran et al. MEDICINAL RESEARCH REVIEWS
- Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
- (2018) Raquel Maia et al. MOLECULES
- Targeting deubiquitinase USP28 for cancer therapy
- (2018) Xiaofang Wang et al. Cell Death & Disease
- Tumor Angiogenesis: A Key Target for Cancer Therapy
- (2018) Dieter Marmé Oncology Research and Treatment
- Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR)
- (2018) Liming Chang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness
- (2018) Lobna Elkhadragy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
- (2018) Akito Nakamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors
- (2018) Carlos J.A. Ribeiro et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer
- (2018) Jing Li et al. EXPERIMENTAL CELL RESEARCH
- Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
- (2018) Solomon Tadesse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological Inhibition of LSD1 for Cancer Treatment
- (2018) Guan-Jun Yang et al. MOLECULES
- T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice
- (2018) Satoru Matsuda et al. NEUROPSYCHOPHARMACOLOGY
- Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis
- (2018) Guixin Yuan et al. CANCER LETTERS
- Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidines as potent lysine specific demethylase 1 (LSD1/KDM1A) inhibitors
- (2017) Shuai Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer
- (2017) Prashant Joshi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
- (2017) Deepali Waghray et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
- (2017) Ying Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells
- (2017) Lobna Elkhadragy et al. Molecular Oncology
- An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
- (2017) Wei Qi et al. Nature Chemical Biology
- MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1
- (2017) Yu Shuang et al. ONCOLOGY REPORTS
- MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting DCUN1D1
- (2017) Jing Xiao et al. ONCOLOGY RESEARCH
- Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors
- (2017) Zhong-Hua Li et al. ACS Medicinal Chemistry Letters
- A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation
- (2017) Haibin Zhou et al. Nature Communications
- Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?
- (2016) Nuggehally R. Srinivas CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis
- (2016) Tedman Ehlers et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Advances in structure-based drug discovery of carbonic anhydrase inhibitors
- (2016) Claudiu T. Supuran Expert Opinion on Drug Discovery
- Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins
- (2016) Brigitt Raux et al. JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer
- (2016) Zhaojing Jiang et al. Oncotarget
- Casein kinases as potential therapeutic targets
- (2015) Giorgio Cozza et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration
- (2015) Rania Al-Mahdi et al. Cell Adhesion & Migration
- Amino Acid Deprivation Promotes Tumor Angiogenesis through the GCN2/ATF4 Pathway
- (2015) Yugang Wang et al. NEOPLASIA
- Regulation of USP28 Deubiquitinating Activity by SUMO Conjugation
- (2014) Yang Zhen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ERK3 Promotes Endothelial Cell Functions by Upregulating SRC-3/SP1-Mediated VEGFR2 Expression
- (2014) Wei Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical Targeting of Mutated and Wild-Type Protein Tyrosine Kinases in Cancer
- (2014) J. M. Drake et al. MOLECULAR AND CELLULAR BIOLOGY
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- The Non-Classical MAP Kinase ERK3 Controls T Cell Activation
- (2014) Miriam Marquis et al. PLoS One
- Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening
- (2013) Lewis R. Vidler et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
- (2013) A. E. Prota et al. SCIENCE
- Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside
- (2012) Christos D. Katsetos et al. CURRENT PHARMACEUTICAL DESIGN
- Proteasome deubiquitinases as novel targets for cancer therapy
- (2012) Pádraig D’Arcy et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Extracellular Signal-Regulated Kinase 3 (Mitogen-Activated Protein Kinase 6 [MAPK6])-MAPK-Activated Protein Kinase 5 Signaling Complex Regulates Septin Function and Dendrite Morphology
- (2012) F. Brand et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
- (2011) Michael Frezza et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Histone onco-modifications
- (2011) J Füllgrabe et al. ONCOGENE
- PAX2 in human kidney malformations and disease
- (2011) Lyndsay A. Harshman et al. PEDIATRIC NEPHROLOGY
- Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents
- (2010) Nam Doo Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY
- How do tumours adapt to nutrient stress?
- (2010) Ronald C Wek et al. EMBO JOURNAL
- The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
- (2010) Jiangbin Ye et al. EMBO JOURNAL
- A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors
- (2010) Andrea Wang-Gillam et al. INVESTIGATIONAL NEW DRUGS
- Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402
- (2009) Christoph M. Dehnhardt et al. JOURNAL OF MEDICINAL CHEMISTRY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage
- (2009) Felipe Cortes Ledesma et al. NATURE
- Next generation oncology drug development: opportunities and challenges
- (2009) Martin E. Gutierrez et al. Nature Reviews Clinical Oncology
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Breaking the chains: structure and function of the deubiquitinases
- (2009) David Komander et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality
- (2009) S. Klinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TTI-237: A Novel Microtubule-Active Compound with In vivo Antitumor Activity
- (2008) C. F. Beyer et al. CANCER RESEARCH
- Dcn1 Functions as a Scaffold-Type E3 Ligase for Cullin Neddylation
- (2008) Thimo Kurz et al. MOLECULAR CELL
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now